Mayur Jayant Amin, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 64 Rehab Lane, Danville, PA 17822 Phone: 570-271-5129 |
Benjamin Davis, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6211 |
Dr. Shaik Mohd L Ahmed, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 16 Woodbine Lane, Danville, PA 17822 Phone: 570-271-6621 Fax: 570-271-5655 |
Dr. Denise M. Enari, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2 Rehab Lane, Danville, PA 17822 Phone: 570-271-6110 Fax: 570-214-9718 |
Dr. Chun Ho, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 64 Rehab Ln, Danville, PA 17821 Phone: 570-271-6110 Fax: 570-214-9718 |
Dr. Chulhyun Ahn, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 16 Woodbine Ln, Danville, PA 17821 Phone: 570-271-6621 Fax: 570-271-5655 |
Dr. Edward William Heinle Iii, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 16 Woodbine Ln, Danville, PA 17821 Phone: 570-271-6621 Fax: 570-271-5655 |
News Archive
GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced that a pilot study of the company's lead candidate, GMI-1070, is underway in sickle cell patients. The first patients in this pilot study were treated at Children's Hospital & Research Center Oakland in California.
The University of Illinois is set to receive a grant from the Friends of Mel Foundation (FOM) in support of their Bone Marrow Transplant Program. The program was selected as the recipient of the Mel's Magic award for January 2011. Mel's Magic was created by FOM in May 2009 to familiarize their supporters with other organizations that work tirelessly to make a difference in the cancer community.
China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced financial and operational results for the three month ended September 30, 2009, or the first quarter of fiscal year 2010.
Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.
Pearl Scott lifts the baby from the crib and balances the child on her hip, just as someone did with her when she was a baby 20 years ago. Her mom went through addiction treatment here in the Native American Rehabilitation Association of the Northwest's residential center. Now Scott works for NARA, operated by and for Native Americans. She helps care for the 10 children, all 5 years old and younger, of parents in treatment.
› Verified 5 days ago